3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Promyelocytic, Acute
3
Thrombocytopenia
2
Pathologic Complete Response
2
Uterine Cervical Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lung Neoplasms
1
Leukemia
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Busulfan
5
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Melphalan
4
Azacitidine
4
venetoclax
3
fludarabine
3
Tacrolimus
3
Cyclosporine
3
Biopsy
3
Vorinostat
2
Specimen Handling
2
Rituximab
2
Methotrexate
2
Etoposide
2
Cytarabine
2
Antilymphocyte Serum
2
thymoglobulin
1
pegylated granulocyte colony-stimulating factor
1
merphos
1
ivosidenib
1
decitabine and cedazuridine drug combination
1
cedazuridine
1
Thiotepa
1
TAK-243
1
Stem Cell Transplantation
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Refractory, with Excess of Blasts
×
Tretinoin
×
90 days
×
Clear all
No trials found.